NORGES BANK - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 116 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2022$986,003
-34.2%
249,6210.0%0.00%
Q3 2022$1,497,726
-6.7%
249,6210.0%0.00%
Q2 2022$1,605,063
+573.1%
249,621
+764.6%
0.00%
Q1 2022$238,466
-46.7%
28,8700.0%0.00%
Q4 2021$447,00028,8700.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders